Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
about
Current Issues and Clinical Evidence in Tumor-Infiltrating Lymphocytes in Breast CancerStrategies and Advancements in Harnessing the Immune System for Gastric Cancer ImmunotherapyImmunity of human epithelial ovarian carcinoma: the paradigm of immune suppression in cancerNovel immunotherapeutic strategies of gastric cancer treatmentTumor infiltrating lymphocytes in ovarian cancerTumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysisAn immunologic portrait of cancerPeripheral blood immune cell methylation profiles are associated with nonhematopoietic cancersTumor-infiltrating T cells correlate with NY-ESO-1-specific autoantibodies in ovarian cancer.Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factorsDifferent subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.Ovarian cancer immunotherapy: opportunities, progresses and challengesTumor-associated macrophages contribute to tumor progression in ovarian cancer.Prognostic impact of lymphocytes in soft tissue sarcomasPrognostic value of progesterone receptor expression in ovarian cancer: a meta-analysisIntraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinomaSuccessful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.Depletion of regulatory T lymphocytes reverses the imbalance between pro- and anti-tumor immunities via enhancing antigen-specific T cell immune responsesPrognostic significance of B-cells and pSTAT3 in patients with ovarian cancer.Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.The value of tumor infiltrating lymphocytes (TILs) for predicting response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancerThe emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade.Whole tumor antigen vaccines.Interleukin-6 receptor and its ligand interleukin-6 are opposite markers for survival and infiltration with mature myeloid cells in ovarian cancer.Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology.Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunityGastric cancer and the epoch of immunotherapy approachesRepeated intratumoral administration of ONCOS-102 leads to systemic antitumor CD8+ T-cell response and robust cellular and transcriptional immune activation at tumor site in a patient with ovarian cancer.Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.Comparative study of various subpopulations of cytotoxic cells in blood and ascites from patients with ovarian carcinoma.Intraepithelial T cells and tumor-associated macrophages in ovarian cancer patients.Multifaceted therapeutic targeting of ovarian peritoneal carcinomatosis through virus-induced immunomodulationTumor-associated lymphocytes predict response to neoadjuvant chemotherapy in breast cancer patientsTargeting AMPK signaling in combating ovarian cancers: opportunities and challenges.A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer.HLA ligandomics identifies histone deacetylase 1 as target for ovarian cancer immunotherapy.
P2860
Q26798074-C24C726D-59A9-471B-AAF9-8EBFF3DD46CDQ26823515-C41E4D84-884E-48AA-ABCB-F4E9D37BFD1BQ26996829-62961E01-443F-476C-847F-4D7D2A3BBFEDQ27011232-4F87E046-D600-4583-BCF7-4255E3B2C19AQ27021878-5D34D942-75D6-4392-ABFE-622B5D1B9084Q27024810-432BCD51-A0D0-422F-8651-9DDC85BF845DQ27028000-568EC638-70B2-4A9A-A079-1F0987268085Q28387330-D4F14E7C-27F4-4CA6-9D93-9AB5A2072FC9Q33377058-001CDA81-1616-4218-AFF4-35D73E440AB1Q33488520-1A57CB22-50E2-495E-A026-CE99B3190C7FQ33638975-2369B2DC-674B-4D32-9EF1-2ECCB6F0E153Q33702218-97594241-490B-403F-A88A-0688A29751C7Q33718878-988736F3-3FC7-4B57-8744-843BA9D170B2Q33813250-55EE57B0-D207-4062-B823-FFA0F20788B6Q33829679-ACDAF7A2-4543-4E42-BD3F-E17D3064B20FQ33865610-F7A6AC74-194C-4B60-AF97-8C66EA92901DQ34007762-27BC6D78-502C-464E-AFC9-E01FC884ABC4Q34188723-EE967FB8-1308-4D80-AACD-D0DC3C64A4F7Q34451999-55E7847B-2270-4D38-BF3D-DC3AB20E1023Q34552079-9147734C-D67C-4366-908E-E3AAF090B95AQ34557233-BCC19B1D-666F-45EC-8C4B-2CCA0F32E866Q34690824-AD3209D9-C7AB-4B95-8774-1AB0CAAC9FD5Q34989820-1824058A-8039-423F-B6CA-A7C2022F6C33Q35058213-00B86A25-0ECB-4D51-9EB4-346BB0761BE6Q35058235-57FF7BCC-5C8A-4B04-A0D6-A076212E6EABQ35157858-438D3D18-C0CF-476F-8798-1651B35AC0FAQ35214729-1C2A7210-B1FE-4297-BDD2-6FCF6A48CBA4Q35214732-3C70435D-73C0-4202-8007-0D53084B9BF1Q35550879-38A2F6CC-B717-4A7A-B536-FE26C1DCC014Q35588434-6FAD72A0-ADAB-463E-BA3B-4DC7908BE79FQ35625349-16387595-E029-443F-ACD4-B8080C90C7FEQ35798892-6E9F1888-BAD7-4A8A-BC5A-1C2BE23EC913Q35818203-D031B6E2-E685-4986-8F22-2362FEBA0047Q36244004-27E4F2E6-C121-4630-8552-91BCA358A0C2Q36574427-350AA789-847F-43F7-BA21-8A2EBE3C442AQ36673709-ED48560F-ED7E-472E-AEE1-257DF6E36036Q36763988-33129E9C-A967-4075-BD8B-0086844318DBQ36949580-C354B1C3-5E6E-469D-A300-51B8E686F851Q36958112-66A7697A-30FB-4B4F-AD12-E5B9ECA31CA4Q37012697-2048DF04-FFF6-4D04-B8A8-7D1DBE54FA24
P2860
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@en
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@nl
type
label
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@en
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@nl
prefLabel
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@en
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@nl
P2093
P1433
P1476
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
@en
P2093
Bohuslav Melichar
Iva Sedláková
Ivo Steiner
Markéta Tomsová
P304
P356
10.1016/J.YGYNO.2007.10.016
P407
P577
2007-11-26T00:00:00Z